FDA advisers narrowly vote in favor of Pfizer’s RSV vaccine for older adults, despite possible safety concerns – CNN

February 28, 2023 by quixnet

FDA advisers narrowly vote in favor of Pfizer’s RSV vaccine for older adults, despite possible safety concernsCNN
Paving the way for the world’s first RSV vaccine, FDA advisers recommend shot from PfizermsnNOW
Pfizer, BioNTech Submit sBLA for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 VaccinePharmacy Times
FDA advisors recommend first-ever RSV vaccine from Pfizer, despite possible Guillain-Barre risksCNBC